Lab stability data worth knowing Published stability studies on semaglutide provide concrete numbers
Wegovy can cause some common digestive system side effects, such as nausea, vomiting, or diarrhoea (as indicated in the Patient Information Leaflet)
Iven J, Biesiekierski JR, Zhao D, et al
Semaglutide belongs to a class of drugs known as glucagon-like peptide 1 agonists, or GLP-1 for short, which mimic the natural digestive hormones that control insulin and, as a side effect, makes you feel full for longer
It is now approved for several conditions: As a once-weekly injection in 0.5 mg, 1 mg, and 2 mg doses as an adjunct to diet and exercise for blood glucose management type 2 diabetes under the Ozempic label